Algert Global’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
+114,499
| New | +$1.3M | 0.03% | 751 |
|
|
2023
Q4 | – | Sell |
-42,371
| Closed | -$333K | – | 1218 |
|
|
2023
Q3 | $333K | Hold |
42,371
| – | – | 0.02% | 865 |
|
|
2023
Q2 | $423K | Buy |
42,371
+2,160
| +5% | +$21.6K | 0.02% | 841 |
|
|
2023
Q1 | $357K | Buy |
40,211
+13,907
| +53% | +$123K | 0.02% | 902 |
|
|
2022
Q4 | $289K | Buy |
26,304
+3,710
| +16% | +$40.8K | 0.02% | 937 |
|
|
2022
Q3 | $294K | Buy |
22,594
+7,614
| +51% | +$99.1K | 0.02% | 952 |
|
|
2022
Q2 | $190K | Buy |
+14,980
| New | +$190K | 0.01% | 1035 |
|
|
2022
Q1 | – | Sell |
-13,053
| Closed | -$378K | – | 1269 |
|
|
2021
Q4 | $378K | Sell |
13,053
-460
| -3% | -$13.3K | 0.05% | 646 |
|
|
2021
Q3 | $405K | Buy |
+13,513
| New | +$405K | 0.05% | 632 |
|